Ratings Execus S.p.A.

Equities

EXEC

IT0005557530

Market Closed - Borsa Italiana 11:44:59 2024-05-15 am EDT 5-day change 1st Jan Change
2.22 EUR 0.00% Intraday chart for Execus S.p.A. -0.89% -35.84%

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Advertising & Marketing

1st Jan change Capi. Investor Rating ESG Refinitiv
-35.84% 12.58M -
+26.37% 28.68B
A-
+12.43% 18.91B
B+
+9.18% 13.64B
C-
-2.86% 11.98B
B
+12.27% 11.43B
A-
+17.14% 4.92B
A-
-17.98% 3.58B -
C-
+3.10% 3.56B
C+
+34.01% 3.54B
C
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW